The IPA network showed that these 81 differential metabolites were associated with neuregulin signaling [29], PI3K-AKT signaling [30], mTOR signaling [31], and ERK/MAPK signaling [32], and all four pathways were associated with neurodegenerative diseases. This evidence concerns the gene AKT1 and neurodegenerative disease.